Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis [Phase 3]
Phase 3 clinical trial update evaluating Lebrikizumab for moderate-to-severe atopic hand and foot dermatitis. The study is currently active …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden [Phase 4]
Phase 4 study to evaluate Lebrikizumab in adults and adolescents with moderate atopic dermatitis and high itch burden; recruitment is ongoin…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab [Phase 3]
This clinical trial update reports ongoing recruitment for a Phase 3 study evaluating Upadacitinib in adults with moderate-to-severe Atopic …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis [Phase 1]
This is a first-in-human Phase 1 study to evaluate REGN20423 in healthy adult participants and adults with atopic dermatitis; the trial is n…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis [Phase 2]
A Phase II clinical study evaluating the efficacy and safety of VC005 in adults with mild to moderate atopic dermatitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis. [Phase 3]
A Phase 3 trial evaluating LNK01001 Capsule for adults with moderate-to-severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis [Phase 1]
A Phase 1 clinical study to evaluate the safety, pharmacokinetics, and efficacy of VC005 in adolescents with mild to moderate atopic dermati…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Therapeutic Efficacy of Cutaneous Application of Postbiotic N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA) in Pediatric Subjects Affected by Atopic Dermatitis [NA]
This clinical-trial update reports on the therapeutic efficacy of a topical postbiotic, N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA), in …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo [Phase 2]
A Phase 2 trial, sponsored by Sanofi, evaluates vaccine responses in adults with atopic dermatitis treated with subcutaneous amlitelimab ver…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD) [Phase 1]
Phase 1 clinical trial evaluating NM26-2198 in healthy subjects and patients with moderate-to-severe Atopic Dermatitis has been terminated.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
This document reports a Phase 2 clinical trial evaluating JNJ-95597528 for moderate to severe atopic dermatitis, currently recruiting partic…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor [Phase 3]
Phase 3 clinical trial evaluating subcutaneous amlitelimab for moderate-to-severe atopic dermatitis in patients 12 and older with inadequate…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis [Phase 2]
This clinical trial update describes a long-term extension study to evaluate the safety and efficacy of Afimkibart (RO7790121) in participan…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis [Phase 4]
Phase 4 study evaluating the long-term effect of dupilumab on skin barrier function in pediatric patients with atopic dermatitis.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials [Phase 2, Phase 3]
A clinical trial update reports long-term safety and efficacy evaluation of amlitelimab in participants from prior atopic dermatitis trials,…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
A French prospective observational study in patients eligible for systemic therapy for atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis [Phase 1]
Phase 1 clinical trial evaluating a skin microbiome-based OTC product for atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks [NA]
A randomized controlled trial comparing topical tacrolimus 0.03% with crisaborole 2% for mild to moderate atopic dermatitis over 8 weeks; th…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Characterization of Chronic Hand Eczema
A clinical trial is characterizing chronic hand eczema and is currently recruiting participants.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Effects of an Emollient Containing Postbiotic Saccharomyces and Lactobacillus on Pediatric Atopic Dermatitis [NA]
A completed pediatric trial evaluated an emollient containing postbiotic Saccharomyces and Lactobacillus for atopic dermatitis.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Metabolic Profiling of Immune Responses in Immune-mediated Diseases
A clinical trial update from NIAID announces ongoing recruitment for a study investigating metabolic profiling of immune responses in immune…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica
A Costa Rican clinical trial is evaluating the treatment of atopic dermatitis with dupilumab in combination with JAK inhibitors; the study i…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
This Phase 2 trial assesses the efficacy and safety of Afimkibart (RO7790121) in participants with moderate to severe atopic dermatitis and …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of SHR-1905 for moderate-to-severe atopic dermatitis and is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating SHR-1819 for moderate-to-severe atopic dermatitis; actively recruiting.